Asamedic Revenue
Pharmaceutical Manufacturing • 
Oslo, Akershus, Norway • 1-10 Employees
Asamedic revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Key Contact at Asamedic
Pawel Lemieszek
Product Development Manager, Head Of Production
Company overview
| Headquarters | Rosenholmveien 25, Nordre Follo, Viken 1414, NO |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
Asamedic Email Formats
Asamedic uses 1 email format. The most common is {first name} (e.g., john@asamedic.no), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@asamedic.no | 100% |
About Asamedic
Asamedic AS is a Norwegian pharmaceutical company focused on its patented emergency heart attack treatment, Coxor®. This fast-acting, fully dissolved acetylsalicylic acid formulation—available as both OTC and Rx—is designed for immediate use at the onset of symptoms, enabling rapid intervention when every second counts. Approved through the European DCP process and launched in Norway, Coxor has been very well received by key opinion leaders, regulatory authorities, and the market. Early commercial uptake has been strong, confirming unmet medical need backed by international guidelines. Asamedic is now actively seeking global licensing and distribution partners to bring this life-saving innovation to new markets.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Asamedic has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Asamedic has never raised funding before.
Belgium
Spain
Australia
Canada
United States
Sweden
IndiaFrequently asked questions
4.8
40,000 users
